-
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma - RNA validation cohort
Study
EGAS50000001212
-
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma - WGS validation cohort
Study
EGAS50000001211
-
Comprehensive molecular profiling with whole-exome sequencing (WES) of PDX tumors
Study
JGAS000853
-
Targeted sequencing data of regulatory regions in 200 Spanish ASD trios
Dac
EGAC50000000695
-
Hi-C analysis of patient-derived pancreas neoplasm organoids
Study
JGAS000262
-
Biobank Japan genotype and phenotype data
Study
JGAS000114
-
Transcriptome sequencing, DNA methylation analysis, and SNP array analysis of acute lymphoblastic leukemia in Down syndrome
Study
JGAS000147
-
Single cell RNA sequencing of human umbilical cord blood lymphoid progenitors
Study
JGAS000551
-
Comprehensive analysis of the abnormality of the genes in juvenile myelomonocytic leukemia
Study
JGAS000292
-
Multi-omics analysis of pediatric high-risk neuroblastoma
Study
JGAS000246
-
intratumor heterogeneity in colorectal adenoma and carcinoma
Study
JGAS000092
-
single cell RNA sequencing and ATAC sequencing, and Whole Genome sequencing of ALS patients
Study
JGAS000852
-
Indonesian Single Cell Data Access Committee
Dac
EGAC50000000870
-
Genome-wide association scan in Parkinson's disease
Study
EGAS00000000034
-
Treatment of CAR T cells with immunomodulatory metabolites
Study
EGAS50000001386
-
Extrachromosomal DNA-driven oncogene dosage heterogeneity determines therapy response in neuroblastoma
Study
EGAS50000001040
-
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH
Study
EGAS00001002618
-
metastatic uveal melanoma tumour biopsies
Study
EGAS50000000864
-
metastatic uveal melanoma tumour biopsies (n=35)
Study
EGAS50000000836
-
A Novel APP p.V742L variant in a patient with ischemic small vessel disease enhances FE65 signalling
Study
EGAS50000001283
-
Comprehensive genomic characterization of early stage bladder cancer - nanopore sequencing
Study
EGAS50000000510
-
Using RNA-sequencing to characterize the resistance to lirafugratinib
Study
EGAS50000001370
-
RNA004 Nanopore DRS of peripheral blood
Study
EGAS50000001201
-
Single cell RNA sequencing of co-culture of human organoids with polarized pro-inflammatory (M1) or anti-inflammatory (M2) macrophages
Study
EGAS50000000467
-
Comprehensive genomic characterization of early stage bladder cancer - shallow whole genome sequencing data
Study
EGAS50000000513